General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Boehringer-Ingelheim(MODEST), Bayer(MODEST), Novartis(MODEST), BMS(MODEST), AstraZeneca(SIGNIFICANT), sanofi-aventis(SIGNIFICANT), Amarin(MODEST), Regeneron(MODEST), Pfizer Inc(MODEST), IDORSIA(MODEST), PhaseBio(MODEST), Novo Nordisk(MODEST) SPEAKER'S BUREAU: Amgen Inc.(MODEST) RESEARCH/RESEARCH GRANTS: Sanofi-Aventis(MODEST), Servier(SIGNIFICANT), Merck & Co., Inc.(SIGNIFICANT), Bayer(SIGNIFICANT)

View Full Disclosure